Department of Nephrology, First Affiliated Hospital of Zhengzhou University, Zhengzhou University Institute of Nephrology, Zhengzhou, 450052, China.
J Clin Immunol. 2014 Feb;34(2):224-32. doi: 10.1007/s10875-013-9970-6. Epub 2013 Dec 12.
IgA nephropathy (IgAN) is the most common primary kidney disease, often leading to chronic renal failure. Complement activation products C3a and C5a have broad pro-inflammatory potential through their receptors, C3aR and C5aR, and contribute to the pathogenesis of several inflammatory and autoimmune diseases, but their roles in IgAN are poorly defined.
This study aimed to establish correlations between renal C3a, C5a, C3aR, C5aR, or serum/urinary C3a, C5a with clinical features and renal histopathology in patients with IgAN.
Eighty-three patients with renal biopsy proven IgAN were investigated. Thirty patients fulfilled Haas's II, 30 fulfilled Haas's III and 23 fulfilled Haas's IV criteria. Deposition of C3a and C5a was assessed by immunohistochemistry. C3aR and C5aR mRNAs and proteins in kidney tissue were examined by real-time quantitative PCR (RT-qPCR) and immunohistochemical staining, respectively. C3a and C5a levels were quantified by ELISA in serum and urine samples of 30 IgAN patients, 10 control subjects and 10 septic patients.
Renal C3a and C5a deposition and C3aR and C5aR expression increased with increasing grades of renal pathology in IgAN patients. They positively correlated with proteinuria and serum creatinine (SCr), but not serum C-reactive protein (CRP) or complement 3 (C3). Serum C3a and C5a increased to levels comparable to septic patients but did not differ among IgAN sub-groups. In contrast, urinary C3a and C5a increased significantly and correlated positively with renal pathological grades.
In patients with IgAN, urinary and renal C3a and C5a and renal expression of C3aR and C5aR are significantly correlated with the activity and severity of renal injury. This observation warrants further study into the roles of C3a, C5a and their receptors in the pathogenesis of IgAN and as potential therapeutic targets.
IgA 肾病(IgAN)是最常见的原发性肾脏疾病,常导致慢性肾衰竭。补体激活产物 C3a 和 C5a 通过其受体 C3aR 和 C5aR 具有广泛的促炎潜能,并有助于几种炎症和自身免疫性疾病的发病机制,但它们在 IgAN 中的作用尚未明确。
本研究旨在确定 IgAN 患者肾组织中 C3a、C5a、C3aR、C5aR 或血清/尿液中 C3a、C5a 与临床特征和肾组织病理学之间的相关性。
研究了 83 例经肾活检证实的 IgAN 患者。30 例符合 Haas II 标准,30 例符合 Haas III 标准,23 例符合 Haas IV 标准。通过免疫组织化学评估 C3a 和 C5a 的沉积。通过实时定量 PCR(RT-qPCR)和免疫组织化学染色分别检测肾组织中 C3aR 和 C5aR 的 mRNA 和蛋白。通过 ELISA 定量检测 30 例 IgAN 患者、10 例对照和 10 例脓毒症患者血清和尿液中的 C3a 和 C5a 水平。
IgAN 患者肾组织中 C3a 和 C5a 的沉积以及 C3aR 和 C5aR 的表达随肾病理分级的增加而增加。它们与蛋白尿和血清肌酐(SCr)呈正相关,但与血清 C 反应蛋白(CRP)或补体 3(C3)无关。血清 C3a 和 C5a 升高至与脓毒症患者相当的水平,但在 IgAN 亚组之间没有差异。相比之下,尿 C3a 和 C5a 显著升高,并与肾病理分级呈正相关。
在 IgAN 患者中,尿和肾组织中的 C3a、C5a 以及肾组织中 C3aR 和 C5aR 的表达与肾损伤的活动度和严重程度显著相关。这一观察结果提示进一步研究 C3a、C5a 及其受体在 IgAN 发病机制中的作用以及作为潜在的治疗靶点。